SC 13G/A
POINTSTATE CAPITAL LP filed this form SC 13G/A on 17 Feb 2015
- velhartice.info
 

 
 
 
CUSIP No. 584688105
SCHEDULE 13G
Page 5 of 8


 
Item 1(a)
Name of Issuer:
   
 
The name of the issuer is The Medicines Company (the “Company”).
   
Item 1(b)
Address of Issuer's Principal Executive Offices:
   
 
The Company’s principal executive offices are located at 8 Sylvan Way, Parsippany, New Jersey 07054.
   
Item 2(a)
Name of Person Filing:
   
 
This statement is filed by:
   
 
(i) SteelMill Master Fund, LP, a Cayman Islands exempted limited partnership (“SteelMill”);
   
 
(ii) PointState Capital LP, a Delaware limited partnership (“PointState”), which serves as the investment manager to SteelMill, PointState Fund LP, a Delaware limited partnership (“PointState Fund”), and Conflux Fund LP, a Delaware limited partnership (“Conflux”); and
   
 
(iii) Zachary J. Schreiber (“Mr. Schreiber”), who serves as managing member of PointState Capital GP LLC, a Delaware limited liability company (“PointState GP”), which in turn serves as the general partner of PointState, and who serves as managing member of PointState Holdings LLC, the general partner of SteelMill and PointState Fund, and of Conflux Holdings LLC, the general partner of Conflux (together with SteelMill and PointState Fund, the “Funds”).
   
 
SteelMill, PointState and Mr. Schreiber are hereinafter sometimes collectively referred to as the “Reporting Persons.”  Any disclosures herein with respect to persons other than the Reporting Persons are made on information and belief after making inquiry to the appropriate party.
   
Item 2(b)
Address or Principal Business Office:
   
 
The address of the business office of each of the Reporting Persons is care of PointState Capital LP, 40 West 57th Street, 25th Floor, New York, NY 10019.
   
Item 2(c)
Citizenship:
   
 
 
SteelMill is organized under the laws of the Cayman Islands. PointState is organized under the laws of the State of Delaware.  Mr. Schreiber is a citizen of the United States of America.
   
Item 2(d)
Title of Class of Securities:
   
 
Common Stock, par value $0.001 per share (the “Common Stock”)